Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

sun pharmaceutical industries europe bv - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - diclofenacnatrium - enterotabletter - 50 mg

Европейски съюз - датски - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenemnatrium - bakterieinfektioner - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 og 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmaceutical works polpharma - ramipril - kapsler, hårde - 10 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmaceutical works polpharma - ramipril - kapsler, hårde - 2,5 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmaceutical works polpharma - ramipril - kapsler, hårde - 5 mg

Европейски съюз - датски - EMA (European Medicines Agency)

mylan ireland limited - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiske midler - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg